Silver Spring, Maryland–(ENEWSPF)–December 10, 2015. The U.S. Food and Drug Administration cleared for marketing in the United States the first cooling cap to reduce hair loss (alopecia) in female breast cancer patients undergoing chemotherapy.
FDA Allows Marketing of Cooling Cap to Reduce Hair Loss During Chemotherapy
More in Health and Fitness:
